Brief: LSL Pharma Group Announces CFO Transition
10/09/2026 12:14
BRIEF-LSL Pharma Group Announces CFO Transition Sept 10 (Reuters) - LSL Pharma Group Inc LSL.V:
LSL PHARMA GROUP ANNOUNCES CFO TRANSITION
LSL PHARMA GROUP - LUC MAINVILLE LEAVES POSITION AS CFO EFFECTIVE IMMEDIATELY
LSL PHARMA GROUP - INITIATES SEARCH FOR NEW CHIEF FINANCIAL OFFICER
LSL PHARMA GROUP - FRANÇOIS ROBERGE TEMPORARILY ASSUMES CFO ROLE WITH AUDIT COMMITTEE OVERSIGHT
Source text: ID:nCNW9cBBha
Further company coverage: LSL.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering